UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

PLoS pathogens, 2020-07, Vol.16 (7), p.e1008795-e1008795

2020

Volltextzugriff (PDF)

Cytomegalovirus miRNAs Target Secretory Pathway Genes to Facilitate Formation of the Virion Assembly Compartment and Reduce Cytokine Secretion

Cell host & microbe, 2014-03, Vol.15 (3), p.363-373

2014

Volltextzugriff (PDF)

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs

PLoS pathogens, 2017-01, Vol.13 (1), p.e1006141-e1006141

2017

Volltextzugriff (PDF)

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs

PLoS pathogens, 2018-05, Vol.14 (5), p.e1007095-e1007095

2018

Volltextzugriff (PDF)

Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ

mBio, 2017-03, Vol.8 (2)

2017

Volltextzugriff (PDF)

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

Viruses, 2023-06, Vol.15 (7), p.1483

2023

Volltextzugriff (PDF)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Human vaccines & immunotherapeutics, 2020-09, Vol.16 (9), p.2109-2113

2020

Volltextzugriff (PDF)

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine

Viruses, 2022-03, Vol.14 (3), p.540

2022

Volltextzugriff (PDF)

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

Human vaccines & immunotherapeutics, 2017-12, Vol.13 (12), p.2785-2793

2017

Volltextzugriff (PDF)

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

Vaccine, 2019-01, Vol.37 (4), p.664-669

2019

Volltextzugriff (PDF)

Vaccines to prevent genital herpes

Translational research : the journal of laboratory and clinical medicine, 2020-06, Vol.220, p.138-152

2020

Volltextzugriff (PDF)

Herpes Simplex Virus Type 1 and 2 Glycoprotein C Prevents Complement-Mediated Neutralization Induced by Natural Immunoglobulin M Antibody

Journal of Virology, 2006-04, Vol.80 (8), p.4038-4046

2006

Volltextzugriff (PDF)

Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E

Journal of Virology, 2008-07, Vol.82 (14), p.6935-6941

2008

Volltextzugriff (PDF)

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

Science immunology, 2019-09, Vol.4 (39)

2019

Volltextzugriff (PDF)

Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models

The Journal of clinical investigation, 2021-12, Vol.131 (23)

2021

Volltextzugriff (PDF)

Guinea Pig and Mouse Models for Genital Herpes Infection

Current protocols, 2021-12, Vol.1 (12), p.e332-n/a

2021

Volltextzugriff (PDF)

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

Vaccine, 2019-06, Vol.37 (29), p.3770-3778

2019

Volltextzugriff (PDF)

Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes

Journal of Virology, 2004-10, Vol.78 (19), p.10276-10281

2004

Volltextzugriff (PDF)

Techniques for Characterizing Cytomegalovirus-Encoded miRNAs

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2244, p.301

2021

Volltextzugriff (PDF)

Techniques for characterizing cytomegalovirus-encoded miRNAs

Methods in molecular biology (Clifton, N.J.), 2014-01, Vol.1119, p.239

2014

Volltextzugriff (PDF)

Characterization of a Novel Murine Retrovirus Mixture That Facilitates Hematopoiesis

Journal of Virology, 2002-12, Vol.76 (23), p.12112-12122

2002

Volltextzugriff (PDF)

Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine models

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.64-64.10

2022

Volltextzugriff (PDF)

Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene

Journal of virology, 2000-10, Vol.74 (19), p.8876-8883

2000

Volltextzugriff (PDF)

Genetics of Mouse Mammary Tumor Virus-Induced Mammary Tumors: Linkage of Tumor Induction to the gagGene

Journal of Virology, 2000-10, Vol.74 (19), p.8876

2000

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Animals
(19)
Humans
(14)
Virology
(14)
Female
(11)
Mice
(11)
Guinea Pigs
(9)
Microbiology
(8)
Vaccines
(8)
Glycoprotein D
(7)
Glycoproteins
(7)
Herpes Genitalis - Prevention & Control
(7)
Herpes Viruses
(7)
Immunization
(7)
Infections
(7)
Antibodies
(6)
Immune Evasion
(6)
Immunology
(6)
Antibodies, Viral - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Cytomegalovirus miRNAs Target Secretory Pathway Genes to Facilitate Formation of the Virion Assembly Compartment and Reduce Cytokine Secretion

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs

Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

Vaccines to prevent genital herpes

Herpes Simplex Virus Type 1 and 2 Glycoprotein C Prevents Complement-Mediated Neutralization Induced by Natural Immunoglobulin M Antibody

Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models

Guinea Pig and Mouse Models for Genital Herpes Infection

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes

Techniques for Characterizing Cytomegalovirus-Encoded miRNAs

Techniques for characterizing cytomegalovirus-encoded miRNAs

Characterization of a Novel Murine Retrovirus Mixture That Facilitates Hematopoiesis

Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine models

Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene

Genetics of Mouse Mammary Tumor Virus-Induced Mammary Tumors: Linkage of Tumor Induction to the gagGene

Suchergebnisse filtern